0.05Open0.05Pre Close0 Volume22 Open Interest1.50Strike Price0.00Turnover167.14%IV43.52%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2474Delta0.7807Gamma21.60Leverage Ratio-0.0035Theta0.0001Rho5.34Eff Leverage0.0008Vega
CEL-SCI Stock Discussion
Head and neck cancers (HNC) remain a global health challenge, impacting thousands of individuals each year. Advances in immunotherapy have offered new hope for improving patient outcomes, particularly concerning survival rates. In this context...
No comment yet